During the past decade, KEMRI Wellcome Trust Research Programme conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KEMRI Wellcome Trust Research Programme" #1 sponsor was "University of Oxford" with 8 trials, followed by "London School of Hygiene and Tropical Medicine" with 4 trials sponsored, "Drugs for Neglected Diseases" with 2 trials sponsored, "KEMRI-Wellcome Trust Collaborative Research Program" with 2 trials sponsored and "Anna Griffiths, MRC" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KEMRI Wellcome Trust Research Programme" #1 collaborator was "KEMRI-Wellcome Trust Collaborative Research Program" with 7 trials as a collaborator, "Wellcome Trust" with 5 trials as a collaborator, "Kenya Medical Research Institute" with 3 trials as a collaborator, "PENTA Foundation" with 2 trials as a collaborator and "Sanaria Inc." with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "KEMRI Wellcome Trust Research Programme" are "Malaria" (5 trials), "Neonatal SEPSIS" (2 trials), "Anaemia" (1 trials), "Antibiotic Resistance" (1 trials) and "Antibiotic Toxicity" (1 trials). Many other conditions were trialed in "KEMRI Wellcome Trust Research Programme" in a lesser frequency.

Most popular intervention types in "KEMRI Wellcome Trust Research Programme" are "Biological" (7 trials), "Drug" (7 trials), "Dietary Supplement" (3 trials), "Other" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Albendazole" (2 trials), "4CMenB (Bexsero®) vaccine" (1 trials), "Analysis of Bacterial Isolates" (1 trials), "Artemether lumefantrine" (1 trials) and "Azithromycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "KEMRI Wellcome Trust Research Programme" are 17 trials for "All" genders.

Currently, there are NaN active trials in "KEMRI Wellcome Trust Research Programme". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in KEMRI Wellcome Trust Research Programme, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in KEMRI Wellcome Trust Research Programme, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".